UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050812
Receipt number R000057905
Scientific Title Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease
Date of disclosure of the study information 2023/04/11
Last modified on 2024/01/09 14:08:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease

Acronym

Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease

Scientific Title

Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease

Scientific Title:Acronym

Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease

Region

Japan


Condition

Condition

renal anemia, chronic kidney disease, diabetes mellitus

Classification by specialty

Medicine in general Endocrinology and Metabolism Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Retrospective study to determine the factors influencing the efficacy of roxadustat in non-dialysis CKD patients, with a particular focus on comorbid diabetes.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The changes in the dose over 6 months after initiation of roxadustat

Key secondary outcomes

Changes in hemoglobin levels and achievement rates of target hemoglobin levels over 6 months after initiation of roxadustat


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Non-dialysis patients with chronic kidney disease and renal anemia

Key exclusion criteria

Patients who were transferred to another hospital within a month after the initiation of roxadustat
Patients whose hemoglobin level of 11 g/dL or higher at the initiation of roxadustat

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Ito

Organization

Edogawa Hospital

Division name

Department of Diabetes, Metabolism and Kidney Disease

Zip code

133-0052

Address

2-24-18, Higashikoiwa, Edogawa-ku, Tokyo

TEL

03-3673-1221

Email

ito@edogawa.or.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Ito

Organization

Edogawa Hospital

Division name

Department of Diabetes, Metabolism and Kidney Disease

Zip code

133-0052

Address

2-24-18, Higashikoiwa, Edogawa-ku, Tokyo

TEL

03-3673-1221

Homepage URL


Email

ito@edogawa.or.jp


Sponsor or person

Institute

Edogawa Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Edogawa Hospital

Address

2-24-18, Higashikoiwa, Edogawa-ku, Tokyo

Tel

03-3673-1221

Email

ito@edogawa.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 11 Day


Related information

URL releasing protocol

https://www.cureus.com/articles/156342-relationship-between-the-effect-of-roxadustat-and-comorbid-di

Publication of results

Published


Result

URL related to results and publications

https://www.cureus.com/articles/156342-relationship-between-the-effect-of-roxadustat-and-comorbid-di

Number of participants that the trial has enrolled

44

Results

The comorbidities of DM and BW at baseline were significantly associated with each dose of ROX at 6 M and the change in each dose of ROX. There was no difference in the amount of increase in the Hb level and the rate of Hb target achievement between patients with and without DM. Each dose of ROX gradually decreased in patients without DM, whereas it increased in those with DM. Each dose of ROX was significantly higher in patients with DM than in those without DM at 3 and 6 M after the initiation of ROX.

Results date posted

2024 Year 01 Month 09 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2023 Year 05 Month 26 Day

Baseline Characteristics

44 patients with chronic kidney disease treated using roxadustat

Participant flow

44 patients with chronic kidney disease treated using roxadustat

Adverse events

Adverse events were found in 9 patients

Outcome measures

Hb, dose of roxadustat

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2021 Year 08 Month 02 Day

Date of IRB

2021 Year 08 Month 02 Day

Anticipated trial start date

2021 Year 08 Month 02 Day

Last follow-up date

2022 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

retrospective observation study


Management information

Registered date

2023 Year 04 Month 11 Day

Last modified on

2024 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057905


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name